Want to see CV full AI Analyst Report?
CV Stock Chart & Stats
$13.23
--
Market closed
$13.23
--
Day’s Range― - ―
52-Week Range$3.43 - $15.37
Previous CloseN/A
VolumeN/A
Average Volume (3M)45.47K
Market Cap
$363.73M
Enterprise Value$307.62M
Total Cash (Recent Filing)$17.93M
Total Debt (Recent Filing)$788.00K
Price to Earnings (P/E)―
Beta-1.61
Next Earnings
Aug 13, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding49,963,585
10 Day Avg. Volume21,973
30 Day Avg. Volume45,470
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)197.96
Price to Sales (P/S)193.67
P/FCF Ratio-114.36
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue22.68
Enterprise Value/Gross Profit43.90
Enterprise Value/Ebitda-11.54
Forecast
1Y Price Target
$11.00Price Target Upside-16.86% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.47
Revenue Forecast (FY)$15.80M
Bulls Say, Bears Say
Bulls Say
Top-line Growth & Gross MarginSustained high revenue growth with stable mid-50s gross margins indicates strong product-market fit and scalable unit economics. Over months this supports expanding addressable-market penetration and gives the company room to leverage fixed costs as revenue grows toward durable profitability.
Operating ImprovementNear-breakeven operating performance shows management is exercising spending discipline and realizing operating leverage. Structural improvement at the EBIT/EBITDA line reduces future external funding needs if sustained, improving the path to durable profitability over the medium term.
Low Reported LeverageVery low reported debt relative to equity materially lowers immediate solvency and interest burden risks. A light leverage profile gives the company flexibility to invest or raise capital under less strain, supporting longer-term execution of growth initiatives.
Bears Say
Large Cash BurnConsistent and increasing operating cash outflows indicate the business is not self-funding growth. Persistent high burn requires recurrent external financing or asset sales, creating dilution and execution risk that can materially affect strategic choices and long-term shareholder returns.
Deep Net LossesVery large net losses relative to revenue show the company has structural profitability challenges beyond temporary swings. Even with operating improvement, bottom-line deficits undermine retained capital, limit reinvestment capacity, and increase dependency on external capital to sustain growth.
Prior Negative Equity / Capital DurabilityA history of negative equity signals accumulated losses and prior capital strain, implying limited buffer against future shocks. This structural weakness raises the likelihood of future dilutive financings or constrained strategic options if operating improvements stall.
CapsoVision, Inc. News
CV FAQ
What was CapsoVision, Inc.’s price range in the past 12 months?
CapsoVision, Inc. lowest stock price was $3.43 and its highest was $15.37 in the past 12 months.
What is CapsoVision, Inc.’s market cap?
CapsoVision, Inc.’s market cap is $363.73M.
When is CapsoVision, Inc.’s upcoming earnings report date?
CapsoVision, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 41 days.
How were CapsoVision, Inc.’s earnings last quarter?
CapsoVision, Inc. released its earnings results on May 14, 2026. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.13 by -$0.02.
Is CapsoVision, Inc. overvalued?
According to Wall Street analysts CapsoVision, Inc.’s price is currently Overvalued.
Does CapsoVision, Inc. pay dividends?
CapsoVision, Inc. does not currently pay dividends.
What is CapsoVision, Inc.’s EPS estimate?
CapsoVision, Inc.’s EPS estimate is -0.13.
How many shares outstanding does CapsoVision, Inc. have?
CapsoVision, Inc. has 49,963,585 shares outstanding.
What happened to CapsoVision, Inc.’s price movement after its last earnings report?
CapsoVision, Inc. reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.13. Following the earnings report the stock price went down -11.575%.
Which hedge fund is a major shareholder of CapsoVision, Inc.?
Currently, no hedge funds are holding shares in CV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CapsoVision, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (-16.86% Downside)
$11.00 (-16.86% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
126.84%
Trailing 12-Months
Asset Growth
108.43%
Trailing 12-Months
Company Description
CapsoVision, Inc.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
CV Earnings Call
Q1 2026
0:00 / 0:00
CV Stock 12 Month Forecast
Average Price Target
$11.00
▼(-16.86% Downside)
Technical Analysis
Ownership Overview
2.98% Insiders
3.17% Mutual Funds
0.02% Other Institutional Investors
88.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---